Virtual reality exposure therapy therapy as treatment for pain catastrophizing in fibromylagia patients: Proof-of-concept

inzette Morris0 个研究点目标入组 20 人开始时间: 2010年11月17日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Adult male and female subjects
•Between ages of 18 and 65 years old
•clinically diagnosed with FMS according to the American College Rheumatology (ACR) criteria [26] by a qualified rheumatologist subjectively report high PCS (more than 24 points) and TSK (more than 37 points) scores
•able to speak, read English, Afrikaans and Xhosa

•diagnosed with other conditions not related to FMS i.e. cancer;
•severe physical disabilities;
•suffer from other chronic conditions i.e. systemic lupus erythmatosus, rheumatoid arthritis, etc;
•previously been hospitalized for a major psychiatric disorder;
•uncontrolled endocrine or allergic disorder; using medication other than the prescribed pharmacologic agents for FMS symptoms;
•using any narcotics long-term;
•currently or who have previously abused any illicit substances or alcohol;
•diagnosed with epilepsy, or other conditions contraindicated in the use of visual exposures to stimuli;
•contraindications which prohibit the use of fMRI, i.e. cardiac pacemakers, metal implants, claustrophobia, pregnancy and cochlear implants;
•unable to discontinue intake of anti-depressants 4 weeks prior to commencement of study

发起方

inzette Morris